Wednesday, April 13, 2022

< + > New Analysis Shows Fluvoxamine Has The Potential To Reduce Covid-19 Hospitalizations By More Than 90%

There is an ever-expanding need for SARS-CoV-2 antivirals. A recent analysis suggests fluvoxamine may greatly reduce the risk of hospitalization in Covid patients.

No comments:

Post a Comment

< + > A Look at Workday’s ERP in Healthcare

Healthcare technology conversations often focus on the EHR and clinical systems, but the technology supporting a health system’s HR, finance...